Skip to main content
Erschienen in: Journal of Neurology 9/2010

01.09.2010 | Original Communication

Facioscapulohumeral muscular dystrophy: a prospective study of weakness and functional impairment

verfasst von: Joerg-Patrick Stübgen, Annette Stipp

Erschienen in: Journal of Neurology | Ausgabe 9/2010

Einloggen, um Zugang zu erhalten

Abstract

Only isolated prospective studies have attempted to chart the natural history of facioascapulohumeral muscular dystrophy (FSHD), a benign myopathy with notoriously variable clinical manifestations and progression. This 10-year prospective study was performed to document by simple clinical methods the natural history of 16 patients with moderately advanced FSHD. Limb strength was evaluated by the bedside manual muscle test. Global weakness was documented as a composite average muscle score (AMS). Limb function was evaluated by a non-linear grading system of important functional milestones. A scale of activities of daily living (ADL) was used to assess disability across multiple functional domains in a home environment. Six-monthly evaluations determined a linear deterioration of the mean AMS that reached statistical significance from baseline at the 5-year interval. Half of patients showed a functional decline of the arms by one grade. All patients maintained useful hand function. Three quarters of patients suffered functional decline of the legs, commonly by one grade. All patients remained ambulant. Interval analyses showed a linear deterioration of the mean ADL score that reached statistical significance from baseline at the 5-year interval. Functional deterioration was mostly due to impaired shoulder girdle activities. This study of a relatively homogeneous subgroup of FSHD patients showed a predictable rate of clinical progression in a muscle disease with a notoriously variable clinical presentation and outcome. Natural history data obtained in this study could serve as positive controls for future therapeutic trials in this patient population. The chosen clinical parameters proved useful tools for charting clinical disease progression. Functional tests proved advantageous, because decline was based partly on patient self-reports, thereby improving time and cost effectiveness.
Literatur
1.
Zurück zum Zitat Appel V, Stewart SS, Smith G, Appel SH (1987) A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 22:328–333CrossRefPubMed Appel V, Stewart SS, Smith G, Appel SH (1987) A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 22:328–333CrossRefPubMed
2.
Zurück zum Zitat Bradley WG (1979) The limb-girdle syndromes. In: Vinken PJ, Bruyn GH (eds) Handbook of clinical neurology, vol 40. Elsevier/North Holland, Amsterdam, pp 433–469 Bradley WG (1979) The limb-girdle syndromes. In: Vinken PJ, Bruyn GH (eds) Handbook of clinical neurology, vol 40. Elsevier/North Holland, Amsterdam, pp 433–469
3.
Zurück zum Zitat Brooke MH (1990) Introductory comments on disease-specific tests. Muscle Nerve 13(Suppl):S26–S29 Brooke MH (1990) Introductory comments on disease-specific tests. Muscle Nerve 13(Suppl):S26–S29
4.
Zurück zum Zitat Brooke MH (1990) Introductory comments on disease-specific tests. Muscle Nerve 13(Suppl):S38–S39CrossRefPubMed Brooke MH (1990) Introductory comments on disease-specific tests. Muscle Nerve 13(Suppl):S38–S39CrossRefPubMed
5.
Zurück zum Zitat Brooke MH, Fenichel GM, Griggs RC et al (1989) Duchenne muscular dystrophy: pattern of clinical progression and effects on supportive therapy. Neurology 39:475–481PubMed Brooke MH, Fenichel GM, Griggs RC et al (1989) Duchenne muscular dystrophy: pattern of clinical progression and effects on supportive therapy. Neurology 39:475–481PubMed
6.
Zurück zum Zitat Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, Province MA (1983) Clinical investigation in Duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history. Muscle Nerve 6:91–103CrossRefPubMed Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, Province MA (1983) Clinical investigation in Duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history. Muscle Nerve 6:91–103CrossRefPubMed
7.
Zurück zum Zitat Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ (1981) Clinical trial in Duchenne dystrophy. 1. The design of the protocol. Muscle Nerve 4:186–197CrossRefPubMed Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ (1981) Clinical trial in Duchenne dystrophy. 1. The design of the protocol. Muscle Nerve 4:186–197CrossRefPubMed
8.
Zurück zum Zitat Bunch WH, Siegel IM (1993) Scapulothoracic arthrodesis in facioscapulohumeral muscular dystrophy. Review of seventeen procedures with three to twenty-one-year follow-up. J Bone Joint Surg Am 75:372–376PubMed Bunch WH, Siegel IM (1993) Scapulothoracic arthrodesis in facioscapulohumeral muscular dystrophy. Review of seventeen procedures with three to twenty-one-year follow-up. J Bone Joint Surg Am 75:372–376PubMed
9.
Zurück zum Zitat Carroll JE (1979) Facioscapulohumeral and scapuloperoneal syndromes. In: Vinken PJ, Bruyn GH (eds) Handbook of clinical neurology vol 40. Elsevier/North Holland, Amsterdam, pp 415–431 Carroll JE (1979) Facioscapulohumeral and scapuloperoneal syndromes. In: Vinken PJ, Bruyn GH (eds) Handbook of clinical neurology vol 40. Elsevier/North Holland, Amsterdam, pp 415–431
10.
Zurück zum Zitat Cuthbert SC, Goodheart GJ (2007) On the reliability and validity of manual muscle testing: a literature review. Chiropr Osteopat 15:4–27CrossRefPubMed Cuthbert SC, Goodheart GJ (2007) On the reliability and validity of manual muscle testing: a literature review. Chiropr Osteopat 15:4–27CrossRefPubMed
11.
Zurück zum Zitat Florence JM, Pandya S, King WM, Robison JD, Baty J, Miller JP, Schierbecker J, Signore LC (1992) Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne’s muscular dystrophy. Phys Ther 72:115–126PubMed Florence JM, Pandya S, King WM, Robison JD, Baty J, Miller JP, Schierbecker J, Signore LC (1992) Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne’s muscular dystrophy. Phys Ther 72:115–126PubMed
12.
Zurück zum Zitat Gresham GE, Phillips TF, Labi ML (1980) ADL status in stroke: relative merits of three standard indices. Arch Phys Med Rehabil 61:355–358PubMed Gresham GE, Phillips TF, Labi ML (1980) ADL status in stroke: relative merits of three standard indices. Arch Phys Med Rehabil 61:355–358PubMed
13.
Zurück zum Zitat Hasselkus BR, Safrit MJ (1976) Measurement in occupational therapy. Am J Occup Ther 30:429–437PubMed Hasselkus BR, Safrit MJ (1976) Measurement in occupational therapy. Am J Occup Ther 30:429–437PubMed
14.
Zurück zum Zitat Kasakov V, Rudenko DI (1995) Clinical variability in facioscapulohumeral muscular dystrophy in Russia. Muscle Nerve 18(Suppl 2):S85–S95CrossRef Kasakov V, Rudenko DI (1995) Clinical variability in facioscapulohumeral muscular dystrophy in Russia. Muscle Nerve 18(Suppl 2):S85–S95CrossRef
15.
Zurück zum Zitat Kilmer DD, Abresch RT, McCrory MA, Carter GT, Fowler WM, Johnson ER, McDonald CM (1995) Profiles in neuromuscular diseases: facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil 74(Suppl):S131–S139CrossRefPubMed Kilmer DD, Abresch RT, McCrory MA, Carter GT, Fowler WM, Johnson ER, McDonald CM (1995) Profiles in neuromuscular diseases: facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil 74(Suppl):S131–S139CrossRefPubMed
16.
Zurück zum Zitat Korner-Bitensky N, Wood-Dauphinee S (1995) Barthel Index information elicited over the telephone. Is it reliable? Am J Phys Med Rehabil 74:9–18CrossRefPubMed Korner-Bitensky N, Wood-Dauphinee S (1995) Barthel Index information elicited over the telephone. Is it reliable? Am J Phys Med Rehabil 74:9–18CrossRefPubMed
17.
Zurück zum Zitat Lue YJ, Chen SS (2000) Strength and functional performance of patients with limb girdle muscular dystrophy. Kaohsiung J Med Sci 16:83–90PubMed Lue YJ, Chen SS (2000) Strength and functional performance of patients with limb girdle muscular dystrophy. Kaohsiung J Med Sci 16:83–90PubMed
18.
Zurück zum Zitat Lue YJ, Su CY, Yang RC, Su WL, Lu YM, Lin RF, Chen SS (2006) Development and validation of muscular dystrophy-specific functional rating scale. Clin Rehabil 20:804–817PubMed Lue YJ, Su CY, Yang RC, Su WL, Lu YM, Lin RF, Chen SS (2006) Development and validation of muscular dystrophy-specific functional rating scale. Clin Rehabil 20:804–817PubMed
19.
Zurück zum Zitat Lunt PW, Jardine PE, Koch MC, Maynard J, Osborn M, Williams M, Harper PS, Upadhyaya M (1995) Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Gene 4:951–958CrossRef Lunt PW, Jardine PE, Koch MC, Maynard J, Osborn M, Williams M, Harper PS, Upadhyaya M (1995) Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Gene 4:951–958CrossRef
20.
Zurück zum Zitat Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel Index. Md Med J 14:61–65 Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel Index. Md Med J 14:61–65
21.
Zurück zum Zitat Marino M, Nicholas JA, Gleim GW, Rosenthal P, Nicholas SJ (1982) The efficacy of manual assessment of muscle strength using a new device. Am J Sports Med 10:360–364CrossRefPubMed Marino M, Nicholas JA, Gleim GW, Rosenthal P, Nicholas SJ (1982) The efficacy of manual assessment of muscle strength using a new device. Am J Sports Med 10:360–364CrossRefPubMed
22.
Zurück zum Zitat Medical Research Council (1976) Aids to the investigation of peripheral nerve injuries. Her Majesty’s Stationary Office, London Medical Research Council (1976) Aids to the investigation of peripheral nerve injuries. Her Majesty’s Stationary Office, London
23.
24.
Zurück zum Zitat Mendell JR, Province MA, Moxley RT et al (1987) Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls. Arch Neurol 44:808–811PubMed Mendell JR, Province MA, Moxley RT et al (1987) Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls. Arch Neurol 44:808–811PubMed
26.
Zurück zum Zitat Munsat TL (1990) Clinical trials in neuromuscular disease. Muscle Nerve 13 (Suppl):S3–S6 27. Munsat TL (1994) Facioscapulohumeral disease and the scapuloperoneal syndrome. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 1220–1232 Munsat TL (1990) Clinical trials in neuromuscular disease. Muscle Nerve 13 (Suppl):S3–S6 27. Munsat TL (1994) Facioscapulohumeral disease and the scapuloperoneal syndrome. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 1220–1232
27.
Zurück zum Zitat Munsat TL, Andres PL, Finison L, Conlon T, Thibodeau L (1988) The natural history of motorneuron loss in amyotrophic lateral sclerosis. Neurology 38:409–413PubMed Munsat TL, Andres PL, Finison L, Conlon T, Thibodeau L (1988) The natural history of motorneuron loss in amyotrophic lateral sclerosis. Neurology 38:409–413PubMed
28.
Zurück zum Zitat Padberg GW (1982) Facioscapulohumeral disease. Doctoral thesis, University of Leiden, Intercontinental Graphics Padberg GW (1982) Facioscapulohumeral disease. Doctoral thesis, University of Leiden, Intercontinental Graphics
29.
Zurück zum Zitat Padberg GW, Frants RR, Brouner OF, Wijmega C, Bakker E, Sandkuijl LA (1995) Facioscapulohumeral muscular dystrophy in the Dutch Population. Muscle Nerve 18(Suppl 2):S81–S84CrossRef Padberg GW, Frants RR, Brouner OF, Wijmega C, Bakker E, Sandkuijl LA (1995) Facioscapulohumeral muscular dystrophy in the Dutch Population. Muscle Nerve 18(Suppl 2):S81–S84CrossRef
30.
Zurück zum Zitat Padberg GW, Lunt PW, Koch M, Fardeau M (1991) Diagnostic criteria for facioscapulohumeral dystrophy. Neuromuscul Disord 1:231–234CrossRefPubMed Padberg GW, Lunt PW, Koch M, Fardeau M (1991) Diagnostic criteria for facioscapulohumeral dystrophy. Neuromuscul Disord 1:231–234CrossRefPubMed
31.
Zurück zum Zitat Personius KE, Pandya S, King W, Tawil R, McDermott MP (1994) Facioscapulo- humeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. Phys Ther 74:253–263PubMed Personius KE, Pandya S, King W, Tawil R, McDermott MP (1994) Facioscapulo- humeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. Phys Ther 74:253–263PubMed
32.
Zurück zum Zitat Ricci E, Galluzzi G, Deidda G et al (1999) Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of Kpni repeats at the 4q35 locus and clinical phenotype. Ann Neurol 45:751–757CrossRefPubMed Ricci E, Galluzzi G, Deidda G et al (1999) Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of Kpni repeats at the 4q35 locus and clinical phenotype. Ann Neurol 45:751–757CrossRefPubMed
33.
Zurück zum Zitat Shinar D, Gross CR, Bronstein KS et al (1987) Reliability of the activities of daily living scale and its use in telephone interview. Arch Phys Med Rehabil 68:723–728PubMed Shinar D, Gross CR, Bronstein KS et al (1987) Reliability of the activities of daily living scale and its use in telephone interview. Arch Phys Med Rehabil 68:723–728PubMed
34.
Zurück zum Zitat Tawil R, Figlewicz DA, Griggs RC, Weiffenbach B, the FSH Consortium (1998) Facioscapulohumeral dystrophy. A distinct regional myopathy with a novel molecular pathogenesis. Ann Neurol 43:279–282CrossRefPubMed Tawil R, Figlewicz DA, Griggs RC, Weiffenbach B, the FSH Consortium (1998) Facioscapulohumeral dystrophy. A distinct regional myopathy with a novel molecular pathogenesis. Ann Neurol 43:279–282CrossRefPubMed
35.
Zurück zum Zitat Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, King W, Weiffenbach B, Figlewicz D (1996) Evidence for anticipation and association of deletion size with the severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann Neurol 39:744–748CrossRefPubMed Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, King W, Weiffenbach B, Figlewicz D (1996) Evidence for anticipation and association of deletion size with the severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann Neurol 39:744–748CrossRefPubMed
36.
Zurück zum Zitat Tawil R, van der Maarel SM (2006) Facioscapulohumeral muscular dystrophy. Muscle Nerve 4:1–15CrossRef Tawil R, van der Maarel SM (2006) Facioscapulohumeral muscular dystrophy. Muscle Nerve 4:1–15CrossRef
37.
Zurück zum Zitat The FSH-DY group (1997) A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy. Neurology 48:38–46 The FSH-DY group (1997) A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy. Neurology 48:38–46
38.
Zurück zum Zitat Tindall RSA, Rollins JA, Phillips JT, Greenlee RG, Wells L, Belendink G (1987) Preliminary results of a double blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl J Med 316:719–724CrossRefPubMed Tindall RSA, Rollins JA, Phillips JT, Greenlee RG, Wells L, Belendink G (1987) Preliminary results of a double blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl J Med 316:719–724CrossRefPubMed
39.
Zurück zum Zitat Twyman RS, Harper GD, Edgar MA (1996) Thoracoscapular fusion in facioscapulohumeral muscular dystrophy: clinical review of a new surgical method. J Shoulder Elbow Surg 5:201–205CrossRefPubMed Twyman RS, Harper GD, Edgar MA (1996) Thoracoscapular fusion in facioscapulohumeral muscular dystrophy: clinical review of a new surgical method. J Shoulder Elbow Surg 5:201–205CrossRefPubMed
40.
Zurück zum Zitat Vignos PJ, Spencer GE, Archibald KC (1963) Management of progressive muscular dystrophy in childhood. JAMA 84:89–96 Vignos PJ, Spencer GE, Archibald KC (1963) Management of progressive muscular dystrophy in childhood. JAMA 84:89–96
41.
Zurück zum Zitat Wadsworth CT, Krishnan R, Sear M, Harrold J, Nielsen DH (1987) Intrarater reliability of manual muscle testing and hand-held dynametric muscle testing. Phys Ther 67:1342–1347PubMed Wadsworth CT, Krishnan R, Sear M, Harrold J, Nielsen DH (1987) Intrarater reliability of manual muscle testing and hand-held dynametric muscle testing. Phys Ther 67:1342–1347PubMed
Metadaten
Titel
Facioscapulohumeral muscular dystrophy: a prospective study of weakness and functional impairment
verfasst von
Joerg-Patrick Stübgen
Annette Stipp
Publikationsdatum
01.09.2010
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 9/2010
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-010-5544-1

Weitere Artikel der Ausgabe 9/2010

Journal of Neurology 9/2010 Zur Ausgabe

Medical Progress in the Journal of Neurology

Advances in multiple sclerosis research in 2009

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.